Are you sure?

BSE cautions Humet

The management of the Budapest Stock Exchange has issued a warning to listed pharmaceutical company Humet to observe the regulations of the bourse.

The notice comes after the company failed to release its Q1 business report by the designated deadline of mid-May and only published the figures early June.

Humet gave no justification as to why the delay was necessary.

The company may still appeal the BSE reprimand. (Napi Gazdaság)